Position in ABT
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,149,766
-$108,044 QoQ
Shares Held
12,671
+3.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,417
of 2,959 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Continuum Advisory, LLC holds $3,052,513 across 19 Medical Devices names. ABT ranks #1 (37.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
This page
|
12,671 | $1,149,766 | |
| 2 | SYK |
Stryker Corp
|
1,930 | $607,641 | |
| 3 | BSX |
Boston Scientific Corp
|
12,796 | $546,133 | |
| 4 | MDT |
Medtronic plc
|
6,055 | $473,682 | |
| 5 | DXCM |
Dexcom Inc
|
1,146 | $77,183 | |
| 6 | EW |
Edwards Lifesciences Corp
|
581 | $52,557 | |
| 7 | PODD |
Insulet Corp
|
299 | $45,522 | |
| 8 | GMED |
Globus Medical Inc
|
319 | $25,204 |
All Filings in ABT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,149,766 | 12,671 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,257,810 | 12,251 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,532,421 | 12,231 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,618,664 | 12,085 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,643,952 | 12,087 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,698,715 | 12,806 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,428,126 | 12,626 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $1,427,633 | 12,522 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $1,139,373 | 10,965 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,236,052 | 10,875 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $680,893 | 6,186 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $646,570 | 6,676 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $718,005 | 6,586 | Shares | Sole | 2023-12-13 | |
| 2023-03-31 | $648,469 | 6,404 | Shares | Sole | 2023-12-13 | |
| 2022-12-31 | $684,650 | 6,236 | Shares | Sole | 2023-12-13 | |
| 2022-09-30 | $626,714 | 6,477 | Shares | Sole | 2023-12-13 | |
| 2022-06-30 | $700,249 | 6,445 | Shares | Sole | 2023-12-13 | |
| 2022-03-31 | $762,475 | 6,442 | Shares | Sole | 2023-12-13 | |
| 2021-12-31 | $794,055 | 5,642 | Shares | Sole | 2023-12-13 | |
| 2021-09-30 | $605,534 | 5,126 | Shares | Sole | 2023-12-13 | |
| 2021-06-30 | $601,097 | 5,185 | Shares | Sole | 2023-12-13 | |
| 2021-03-31 | $621,370 | 5,185 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $630,662 | 5,760 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $628,384 | 5,774 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||